Print this page
The Rutgers University study of the Genetics of Blood Cancers
To enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.
Protocol Number:
002606
Phase:
N/A
Applicable Disease Sites:
Hodgkin's Lymphoma
Leukemia, not otherwise specified
Leukemia, other
Lymphoid Leukemia
Multiple Myeloma
Myeloid and Monocytic Leukemia
Non-Hodgkin's Lymphoma
Other Hematopoietic
Leukemia, not otherwise specified
Leukemia, other
Lymphoid Leukemia
Multiple Myeloma
Myeloid and Monocytic Leukemia
Non-Hodgkin's Lymphoma
Other Hematopoietic
Principal Investigator:
Tara Matise
Scope:
Local
Participating Institutions:
- Rutgers University
For further information about clinical trials, please contact us at 732-235-7356.